BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11425295)

  • 1. An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap.
    Dursun SM; Blackburn JR; Kutcher SP
    Med Hypotheses; 2001 Feb; 56(2):235-43. PubMed ID: 11425295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a biochemical lesion in depression.
    Leonard BE
    J Clin Psychiatry; 2000; 61 Suppl 6():12-7. PubMed ID: 10775019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the neurobiology of depression.
    Nemeroff CB
    Psychopharmacol Bull; 2002; 36 Suppl 2():6-23. PubMed ID: 12490820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation of the lateral habenula in treatment resistant major depression.
    Sartorius A; Henn FA
    Med Hypotheses; 2007; 69(6):1305-8. PubMed ID: 17498883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression.
    Kiss JP
    Neurochem Int; 2008 Jan; 52(1-2):34-9. PubMed ID: 17507113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder: remission of associated symptoms.
    Trivedi MH
    J Clin Psychiatry; 2006; 67 Suppl 6():27-32. PubMed ID: 16848674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monoaminergic theories in depressive illness (author's transl)].
    Zarifian E
    Ann Biol Clin (Paris); 1979; 37(1):21-6. PubMed ID: 443609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines as mediators of depression: what can we learn from animal studies?
    Dunn AJ; Swiergiel AH; de Beaurepaire R
    Neurosci Biobehav Rev; 2005; 29(4-5):891-909. PubMed ID: 15885777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and depression: pathophysiological mechanism or marketing myth?
    Cowen PJ
    Trends Pharmacol Sci; 2008 Sep; 29(9):433-6. PubMed ID: 18585794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of the dopaminergic system as a key component to the understanding of depression.
    Yadid G; Friedman A
    Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term plasticity of visually evoked potentials in humans is altered in major depression.
    Normann C; Schmitz D; Fürmaier A; Döing C; Bach M
    Biol Psychiatry; 2007 Sep; 62(5):373-80. PubMed ID: 17240361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant agents for the treatment of chronic pain and depression.
    Jann MW; Slade JH
    Pharmacotherapy; 2007 Nov; 27(11):1571-87. PubMed ID: 17963465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical antipsychotics in bipolar depression: neurobiological basis and clinical implications.
    Brugue E; Vieta E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):275-82. PubMed ID: 16876306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future brightening for depression treatments.
    Holden C
    Science; 2003 Oct; 302(5646):810-3. PubMed ID: 14593164
    [No Abstract]   [Full Text] [Related]  

  • 17. [Neurophysiology and current trends in research on depression. Remarks on the monoaminergic hypothesis of depression].
    de Montigny C
    Union Med Can; 1977 Jun; 106(6):805-10. PubMed ID: 18834
    [No Abstract]   [Full Text] [Related]  

  • 18. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the molecular treatment of depression].
    Páez X; Hernández L; Baptista T
    Rev Neurol; 2003 Sep 1-15; 37(5):459-70. PubMed ID: 14533097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term adaptive changes induced by serotonergic antidepressant drugs.
    Faure C; Mnie-Filali O; Haddjeri N
    Expert Rev Neurother; 2006 Feb; 6(2):235-45. PubMed ID: 16466303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.